Ventyx Biosciences Shares Are Trading Higher After Oppenheimer Upgraded the Stock From Perform to Outperform and Announced a $12 Price Target. Also, Wells Fargo Upgraded the Stock From Equal-Weight to Overweight and Raised Its Price Target From $7 to $16
在奥本海默将股票从表现上调至跑赢大盘并宣布12美元的目标股价之后，Ventyx Biosciences的股价走高。此外，富国银行将该股从等权重上调至增持，并将其目标股价从7美元上调至16美元